1) Withdrawn drug 
Sibutramine is a centrally-acting serotonin-norepinephrine reuptake inhibitor structurally related to amphetamines, although its mechanism of action is distinct. Sibutramine was originally developed and marketed by Knoll Pharmaceuticals and was most recently manufactured and marketed by Abbott Laboratories before its withdrawal from the market. It...
(sĭ-bu´trә-mēn″) an appetite suppressant used as the hydrochloride salt in treatment of obesity; administered orally.
A common prescription appetite suppressant, it is sold under the brand name Meridia.